Scribble

BIIB Stock Quote Price and Forecast | CNN

BIIB

Biogen Inc.

Key terms

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Jun 12 7:27am ET Scotiabank Sticks to Their Buy Rating for Biogen (BIIB) by TipRanks Jun 11 7:40am ET Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Perspective Therapeutics (CATX) and Biogen (BIIB) by TipRanks Jun 11 4:47am ET Eli Lilly Stock (LLY) Gained on FDA Panel Approval by TipRanks Jun 10 5:35am ET Buy Rating for Biogen Justified by Competitive Edge and FDA Insights on Safety Profiles by TipRanks Jun 09 7:42pm ET Eisai, Biogen say FDA accepted sBLA for monthly LEQEMBI IV maintenance dosing by TipRanks Jun 06 8:20am ET Analysts’ Top Healthcare Picks: Addus Homecare (ADUS), Biogen (BIIB) by TipRanks Jun 05 6:50am ET Analysts Offer Insights on Healthcare Companies: Evolent Health (EVH), Biogen (BIIB) and Axsome Therapeutics (AXSM) by TipRanks Jun 04 9:30am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Jun 03 7:34am ET Biogen, Delta Flight Products collaborate for accessible air travel by TipRanks May 30 11:00pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) and Argenx Se (ARGX) by TipRanks May 30 4:53pm ET Biogen granted marketing authorization for Qalsody by EC by TipRanks May 29 6:46am ET RBC Capital Sticks to Its Buy Rating for Biogen (BIIB) by TipRanks May 28 7:19am ET Biogen reports Leqembi approved for treatment of Alzheimer’s in South Korea by TipRanks May 28 6:50am ET Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI), Biogen (BIIB) and SOPHiA GENETICS (SOPH) by TipRanks May 24 11:18am ET Biotech Alert: Searches spiking for these stocks today by TipRanks May 24 1:51am ET Biogen’s Strategic Diversification and Financial Strategy Garner Outperform Rating by TipRanks May 24 1:48am ET Strategic Acquisitions and Clinical Catalysts Bolster Biogen’s Buy Rating by TipRanks May 22 12:30pm ET Biogen acquiring HI-Bio in increased immunology focus, says William Blair by TipRanks May 22 9:15am ET Biogen’s Strategic Acquisition of HI-Bio and Diversification into Orphan Drug Market Prompt ‘Buy’ Rating by TipRanks May 16 6:55pm ET Biogen: A Balanced View Amidst Setbacks and Alzheimer’s Drug Potential by TipRanks May 16 12:37pm ET Biogen says won’t exercise option to license and lead development of BIIB121 by TipRanks May 16 7:36am ET Biogen (BIIB) Receives a Buy from Truist Financial by TipRanks May 16 7:33am ET Biogen, Ionis terminate development of BIIB105 based on data from ALSpire study by TipRanks May 15 9:01am ET Analysts Are Bullish on These Healthcare Stocks: scPharmaceuticals (SCPH), Optinose (OPTN) by TipRanks May 15 8:21am ET Analysts Are Bullish on These Healthcare Stocks: Taysha Gene Therapies (TSHA), Biogen (BIIB) by TipRanks May 14 7:53pm ET Eisai/Biogen initiate FDA BLA for LEQEMBI by TipRanks May 03 8:08am ET Biogen price target raised to $342 from $339 at HSBC by TipRanks May 02 7:39am ET Biogen reports progress on Corporate Responsibility Priorities by TipRanks Apr 26 7:58am ET Sage Therapeutics price target lowered to $15 from $26 at RBC Capital by TipRanks Apr 26 5:50am ET Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Dexcom (DXCM) and Herbalife (HLF) by TipRanks Apr 26 2:22am ET Buy Rating Justified: Biogen’s Promising Drug Launches and Strategic Growth Initiatives by TipRanks

Yesterday 4:30pm ET Biogen Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights – BIIB by Accesswire Yesterday 3:02pm ET Biogen Inc. Investor Reminder: Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP by Newsfile Yesterday 11:15am ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2024 in Biogen Lawsuit - BIIB by Accesswire Yesterday 11:15am ET Class Action Filed Against Biogen Inc. (BIIB) Seeking Recovery for Investors - Contact Levi & Korsinsky by Accesswire Yesterday 10:50am ET BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm by Newsfile Yesterday 10:45am ET Shareholders of Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB by Accesswire Yesterday 7:50am ET Biogen Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - BIIB by Accesswire Yesterday 5:40am ET Biogen Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB by Accesswire Yesterday 4:20am ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2024 in Biogen Lawsuit - BIIB by Accesswire Yesterday 4:20am ET BIIB LAWSUIT ALERT: Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline by Accesswire Jun 12 4:20pm ET BIIB LAWSUIT ALERT: Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline by Accesswire Jun 12 12:15pm ET July 22, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BIIB by Accesswire Jun 12 7:20am ET Biogen Inc. Class Action: Levi & Korsinsky Reminds Biogen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2024 - BIIB by Accesswire Jun 12 7:20am ET Levi & Korsinsky Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BIIB by Accesswire Jun 12 6:07am ET CLASS ACTION REMINDER: If You Lost Money on Your Biogen Inc. (BIIB) Investment, You are Encouraged to Contact BFA Law Before July 2024 Court Deadline by Newsfile Jun 12 5:15am ET Contact Levi & Korsinsky by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB) by Accesswire Jun 11 6:03pm ET SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen by Newsfile Jun 11 3:45pm ET Contact Levi & Korsinsky by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB) by Accesswire Jun 11 3:22pm ET Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP by Newsfile Jun 11 2:15pm ET Investors who lost money on Biogen Inc. (BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB by Accesswire Jun 11 12:45pm ET Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc.(BIIB) Shareholders by Accesswire Jun 11 10:38am ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB by Newsfile Jun 11 6:55am ET Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BIIB by Accesswire Jun 11 5:20am ET Levi & Korsinsky Reminds Biogen Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2024 - BIIB by Accesswire Jun 10 5:45pm ET Shareholders that lost money on Biogen Inc.(BIIB) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More by Accesswire Jun 10 3:36pm ET BIOGEN REMINDER: If You Suffered Losses on Your Biogen Inc. (BIIB) Investment, You are Encouraged to Contact BFA Law Before Approaching July 2024 Legal Deadline by Newsfile Jun 10 1:50pm ET INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm by Newsfile Jun 10 1:00pm ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2024 in Biogen Inc. Lawsuit - BIIB by Accesswire Jun 10 11:35am ET Biogen Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB by Accesswire Jun 10 11:00am ET Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB by Accesswire Jun 09 11:00am ET The Schall Law Firm Is Urging Investors Who Have Experienced Losses In Biogen Inc. To Reach Out. Please Be Mindful Of The Deadline In This Matter by Accesswire

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Apple CEO Tim Cook speaks during an announcement of new products on the Apple campus in Cupertino, Calif., Monday, June 10, 2024.

Apple is now the most valuable US public company

Geopolitics and trade tensions are among the risks to the global economy identified by the World Bank this week.

Yara Nardi/Reuters

3 risks to global economic growth

MOSCOW, RUSSIA - JANUARY 23: (RUSSIA OUT) People walk past the exchange office with the Euro sign on the facade, on January 23, 2023 in Moscow, Russia. Russia's economy is beginning to feel the weight of Western sanctions, following the start of the war against Ukraine. (Photo by Contributor/Getty Images)

New US sanctions force end of dollar and euro trading on Russia’s main exchange

Keith Gill, a Reddit user credited with inspiring GameStop's rally, during a YouTube livestream arranged on a laptop at the New York Stock Exchange (NYSE) in New York, US, on Friday, June 7, 2024. Keith Gill, whose Roaring Kitty online moniker has sent GameStop Corp. shares surging in the past week, sparked another rally in the video-game retailer after a YouTube post said hed return to the platform Friday for the first time in three years.

Michael Nagle/Bloomberg/Getty Images

Why this meme stock frenzy is different from 2021